What Pemaxa is and what it is used for?
Pemaxa is a medicine used in the treatment of cancer.
Pemaxa is given in combination with cisplatin, another anti-cancer medicine, as treatment for malignant pleural mesothelioma, a form of cancer that affects the lining of the lung, to patients who have not received prior chemotherapy.
Pemaxa is also given in combination with cisplatin for the initial treatment of patients with advanced stage of lung cancer.
Pemaxa can be prescribed to you if you have lung cancer at an advanced stage, if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy.
Pemaxa is also a treatment for patients with advanced stage of lung cancer whose disease has progressed after initial chemotherapy has been used.
Before you take Pemaxa
Do not take Pemaxa
Warnings and precautions
Children and adolescents
There is no relevant use of Pemaxa in the paediatric population.
Other medicines and Pemaxa
Please tell your doctor if you are taking any medicine for pain or inflammation (swelling), such as medicines called “nonsteroidal anti-inflammatory drugs” (NSAIDs), including medicines purchased without a doctor’s prescription (such as ibuprofen). There are many sorts of NSAIDs with different durations of activity. Based on the planned date of your infusion of Pemaxa and/or on the status of your kidney function, your doctor needs to advise you on which medicines you can take and when you can take them. If you are unsure, ask your doctor or pharmacist if any of your medicines are NSAIDs.
Please tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Pregnancy, Breast-feeding and Fertility
If you are pregnant, think you may be pregnant or are planning to have a baby, tell your doctor.The use of Pemaxa should be avoided during pregnancy. Your doctor will discuss with you the potential risk of taking Pemaxa during pregnancy. Women must use effective contraception during treatment with Pemaxa.
If you are breast-feeding, tell your doctor.Breast-feeding must be discontinued during Pemaxa treatment.
Men are advised not to father a child during and up to 6 months following treatment with Pemaxa and should therefore use effective contraception during treatment with Pemaxa and for up to 6 months afterwards. If you would like to father a child during the treatment or in the 6 months following receipt of treatment, seek advice from your doctor or pharmacist. You may want to seek counselling on sperm storage before starting your therapy.
Driving and using machines
Pemaxa may make you feel tired. Be careful when driving a car or using machines.
قبل از مصرف پماکسا
How to take Pemaxa?
The dose of Pemaxa is 500 mg for every square meter of your body’s surface area. Your height and weight are measured to work out the surface area of your body. Your doctor will use this body surface area to work out the right dose for you. This dose may be adjusted, or treatment may be delayed depending on your blood cell counts and on your general condition.
Pemaxa 100 mg: Reconstitute each 100 mg vial with 4.2 ml of 9 mg/ml (0.9%) sodium chloride solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
Pemaxa 500 mg: Reconstitute each 500 mg vial with 20 ml of 9 mg/ml (0.9%) sodium chloride solution for injection, without preservative, resulting in a solution containing 25 mg/ml pemetrexed.
Gently swirl each vial until the powder is completely dissolved. The resulting solution is clear and ranges in color from colorless to yellow or green-yellow.
Reconstituted solution must be further diluted before use. The appropriate volume of reconstituted pemetrexed solution must be further diluted to 100 ml with 9 mg/ml (0.9 %) sodium chloride solution for injection, without preservative, and administered as an intravenous infusion over 10 minutes.
You should usually receive your infusion once every 3 weeks.
When using Pemaxa in combination with cisplatin
The doctor or hospital pharmacist will work out the dose you need based on your height and weight. Cisplatin is also given by infusion into one of your veins, and is given approximately 30 minutes after the infusion of Pemaxa has finished. The infusion of cisplatin lasts approximately 2 hours. You should usually receive your infusion once every 3 weeks.
Additional medicines
Corticosteriods: your doctor will prescribe you steroid tablets (equivalent to 4 mg of dexamethasone twice a day) that you will need to take on the day before, on the day of, and the day after Pemaxa treatment. This medicine is given to you to reduce the frequency and severity of skin reactions that you may experience during your anticancer treatment.
Vitamin supplementation: your doctor will prescribe you oral folic acid (vitamin) or a multivitamin containing folic acid (350 to 1000 micrograms) that you must take once a day while you are taking Pemaxa. You must take at least 5 doses during the seven days before the first dose of Pemaxa. You must continue taking the folic acid for 21 days after the last dose of Pemaxa. You will also receive an injection of vitamin B12 (1000 micrograms) in the week before administration of Pemaxa and then approximately every 9 weeks (corresponding to 3 courses of Pemaxa treatment). Vitamin B12 and folic acid are given to you to reduce the possible toxic effects of the anticancer treatment.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. You must contact your doctor immediately if you notice any of the following:
becoming easily breathless or if you look pale (since you might have less hemoglobin than normal which is very common)
Side effects with Pemaxa may include:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
including Stevens-Johnson syndrome and toxic epidermal necrolysis
Not known side effects (frequency cannot be estimated from the available data):
You might have any of these symptoms and/or conditions. You must tell your doctor as soon as possible when you start experiencing any of these side effects.
How to store Pemaxa?
Keep out of the reach of children.
Store below 30°C. Keep vial in outer carton in order to protect from light.
Protect from freezing.
Reconstituted and infusion solutions should be used immediately.
Do not use this medicine after the expiry date which is stated on the label and carton.
For single-used only. Discard unused portion.
The medicine should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Further information
What Pemaxa contains?
Lyophilized powder for concentrate for solution for infusion containing Pemetrexed (as disodium) 100 mg and 500 mg.
The other ingredients are Mannitol, Sodium hydroxide and Hydrochloric acid.
What Pemaxa looks like and contents of the pack?
Pemaxa is a white to either light yellow or green-yellow Lyophilized powder.
It is supplied in packs containing:
1 x 100 mg vial
1 x 500 mg vial